Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.01 is 100% above its 5-year average of -4.00, near the high end of its 5-year range (-8.36–0.08).
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.07.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:26:11.466Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.01
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
-2.02
EARNINGS PER SHARE (EPS) AVG 5Y
-4.00
EARNINGS PER SHARE (EPS) AVG 10Y
-101378732804.39
EARNINGS PER SHARE (EPS) AVG 15Y
-151156232938.80
EARNINGS PER SHARE (EPS) AVG 20Y
-1472725337990.80
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.50%
CURRENT VS 5Y AVG
+100.25%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
Delcath Systems, Inc.
Market Cap
$547.86M
Earnings Per Share (EPS)
0.01
TTM Avg
N/A
3Y Avg
-2.02
5Y Avg
-4.00
Market Cap
$551.09M
Earnings Per Share (EPS)
-0.88
TTM Avg
-0.82
3Y Avg
-0.78
5Y Avg
-1.65
Market Cap
$561.67M
Earnings Per Share (EPS)
-0.45
TTM Avg
0.12
3Y Avg
-0.31
5Y Avg
-0.31
Market Cap
$569.56M
Earnings Per Share (EPS)
2.13
TTM Avg
0.97
3Y Avg
0.08
5Y Avg
-0.20
Market Cap
$573.38M
Earnings Per Share (EPS)
-0.65
TTM Avg
-0.64
3Y Avg
-0.63
5Y Avg
-1.00
Market Cap
$519.25M
Earnings Per Share (EPS)
-0.78
TTM Avg
-1.17
3Y Avg
-1.45
5Y Avg
-1.68
Market Cap
$517.79M
Earnings Per Share (EPS)
-7.58
TTM Avg
-39.00
3Y Avg
-56.28
5Y Avg
-76.67
Market Cap
$517.73M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.09
3Y Avg
-1.67
5Y Avg
-1.68
Market Cap
$579.88M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.57
3Y Avg
-1.57
5Y Avg
-1.57
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $547.86M | 0.01 | N/A | -2.02 | -4.00 |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | -0.88 | -0.82 | -0.78 | -1.65 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | -0.45 | 0.12 | -0.31 | -0.31 |
| CorMedix Inc. (CRMD)vs › | $569.56M | 2.13 | 0.97 | 0.08 | -0.20 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -0.65 | -0.64 | -0.63 | -1.00 |
| Altimmune, Inc. (ALT)vs › | $519.25M | -0.78 | -1.17 | -1.45 | -1.68 |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | -7.58 | -39.00 | -56.28 | -76.67 |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | -0.67 | -1.09 | -1.67 | -1.68 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | N/A | -1.57 | -1.57 | -1.57 |
| OrthoPediatrics Corp. (KIDS)vs › | $587.93M | -1.68 | -1.67 | -1.05 | -1.14 |
Trailing EPS (TTM)
$0.01
Forward EPS (Est.)
$-0.18
P/E Ratio
1220.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.08 |
| 2022-12-31 | -4.12 |
| 2021-12-31 | -3.59 |
| 2020-12-31 | -8.36 |
| 2019-12-31 | -342.82 |
| 2018-12-31 | -503846.14 |
| 2017-12-31 | -2275919775.64 |
| 2016-12-31 | -452622931118.73 |
| 2015-12-31 | -457509240140.24 |
| 2014-12-31 | -599153734148.44 |
| 2012-12-31 | -26545751109293.85 |
| 2010-12-31 | -37547203613531.35 |
| 2009-12-31 | -5751038641570.99 |
| 2008-12-31 | -3104228754380.96 |
| 2007-12-31 | -5147025690599.48 |
| 2006-12-31 | -5333645066658.91 |
| 2005-12-31 | -1243379587263.64 |
| 2004-12-31 | -2137851189725.02 |
| 2003-12-31 | -1687562217150.85 |
| 2002-12-31 | -13872492826207.96 |
| 2001-12-31 | -4664321523376.17 |
| 2000-12-31 | -18567815501457.58 |
| 1999-12-31 | -21307308590017.34 |
| 1998-12-31 | -74477743458560.20 |
